Infectious: Page 2

Oxford Nanopore, U.K. government partner on pandemic early warning system

By LabPulse.com staff writers

Oxford Nanopore and the U.K. government will create the world's first real-time biosurveillance system to monitor infectious disease outbreaks and assess the threat of emerging pandemics.

November 6, 2024

WHO lists 2 more mpox tests under its emergency use procedure

By LabPulse.com staff writers

The World Health Organization (WHO) has listed two additional IVD tests under its emergency use listing procedure.

October 30, 2024

WHO approves Abbott mpox test for emergency use

By LabPulse.com staff writers

The World Health Organization (WHO) authorized Abbott Laboratories' mpox diagnostic test under its emergency use listing procedure, the first such approval by the agency in its effort to expand the diagnostic capacity of countries facing mpox outbreaks.

October 4, 2024

Abionic sepsis test gets FDA 510(k) clearance

By LabPulse.com staff writers

Abionic, a diagnostics firm specializing in rapid early detection, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its IVD Capsule PSP test for sepsis.

October 3, 2024

Roche launches diagnostic test for 12 respiratory viruses

By LabPulse.com staff writers

Roche Diagnostics has launched its first test using its new high-throughput technology that enables users of Roche's Cobas analyzers to simultaneously test for 12 respiratory viruses.

September 26, 2024

Cepheid partners with Fleming Initiative on antimicrobial resistance

By LabPulse.com staff writers

Diagnostics firm Cepheid has entered a partnership with the Fleming Initiative, a global collaboration established by the Imperial College Healthcare National Health Service Trust and Imperial College London to combat antimicrobial resistance.

September 26, 2024

NIH establishes pandemic preparedness research network

By LabPulse.com staff writers

The U.S. National Institutes of Health (NIH) has established a pandemic preparedness research network for research on the pathogens that are most likely to threaten human health.

September 19, 2024

FDA clears marketing T2 Biosystems Candida test for pediatrics

By LabPulse.com staff writers

T2Candida Panel may get a boost.

September 16, 2024

LuminUltra acquires Genomadix Legionella test assets

By LabPulse.com staff writers

LuminUltra has acquired the Legionella testing business assets of Genomadix, as well as the rights to develop and commercialize further assays and test methods.

September 10, 2024

Seegene launches 3rd RUO mpox assay

By LabPulse.com staff writers

After introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.

September 10, 2024

AI-guided rapid Lyme disease test shows promise for early detection

By LabPulse.com staff writers

A new test under development that uses artificial intelligence (AI) and a format similar to that of at-home COVID-19 tests has been shown to accurately identify Lyme disease within 20 minutes.

August 29, 2024

CDC prioritizes mpox specimens for testing laboratories

By LabPulse.com staff writers

The CDC recommended that all laboratories performing mpox testing send certain types of clinical specimens to a laboratory that can perform clade-specific testing as quickly as possible.

August 28, 2024

Previous Page

Page 2 of 153

Next Page